FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979836687> ?p ?o ?g. }

• W2979836687 abstract "Abstract Evolutionarily-conserved ROR1 and ROR2 are each considered a distinct receptor for Wnt5a, implicated in non-canonical Wnt-signaling involved in organogenesis or cancer metastasis. However, in a companion study we found that Wnt5a could induce ROR1 to complex with ROR2 on leukemia cells of patients with chronic lymphocytic leukemia (CLL). Wnt5a-induced ROR1:ROR2 recruited and activated guanine exchange factors (GEF), which in turn activated Rac1 and RhoA, thereby enhancing leukemia-cell proliferation and migration. To map the domain(s) of ROR1 required for formation of ROR1:ROR2 complexes we studied MEC1, a cell line generated from a patients with CLL that we found expressed Wnt5a and ROR2, but not ROR1. Transfection of MEC1 cells to express ROR1 significantly enhanced MEC1 proliferation and chemokine-induced migration, effects that could be blocked by treatment of MEC1-ROR1 cells with a humanized anti-ROR1 monoclonal antibody (mAb), cirmtuzumab (UC-961). We generated MEC1 cells that expressed vectors encoding full-length ROR1, or each of various truncated-forms of ROR1 lacking distinct structural domains. Fluorescence confocal microscopy and co-immune-precipitation studies found that each of the truncated forms of ROR1, except the truncated ROR1 lacking the extracellular kringle (KNG) domain, could form complexes with ROR2 on transfected MEC1 cells; formation of such complexes could be reduced by treatment of the cells with neutralizing antibodies to Wnt5a. Nevertheless, despite forming complexes with ROR2, only the full-length ROR1 formed complexes with ROR2 that could recruit and activate GEF and thereby activate RhoA and Rac1 in MEC1-ROR1 cells. Moreover, only MEC1-ROR1 cells transfected with full-length ROR1 had enhanced proliferation and chemokine-induced migration relative to that of parental MEC1 cells, which only expressed ROR2; again such effects could be blocked by treatment of the ROR1-transfected MEC1 cells with cirmtuzumab. We also examined the activity of cirmtuzumab against MEC1-ROR1 cells engrafted into immune-deficient Rag2−/− γc−/− mice. First we observed that Rag2−/− γc−/− engrafted with MEC1-ROR1 cells had significantly greater splenic and marrow involvement with CD19+ human leukemia than did littermates infused with equal numbers of MEC1 cells that did not express ROR1. However, treatment of mice engrafted with MEC1-ROR1 with cirmtuzumab significantly inhibited the growth of MEC1-ROR1, completely abrogating the growth advantage that MEC1-ROR1 cells had over that of MEC1 cells in vivo. MEC1-ROR1 cells harvested from mice treated with UC-961 had lost or attenuated expression of ROR1, suggesting that cirmtuzumab selected against MEC1 cells that expressed ROR1. Collectively, these studies reveal that the KRG domain of ROR1 is necessary for it to complex with ROR2 in MEC1 cells, but that full-length ROR1 is required for activation of ROR1:ROR2 complexes leading to the activation of RhoA and Rac1. Furthermore, these studies demonstrate that the anti-ROR1 mAb cirmtuzumab can block the formation of such complexes and impair the capacity of ROR1 to enhance leukemia cells migration and proliferation in vitro and in vivo, providing rationale for ongoing clinical evaluation of this antibody in patients with CLL or other cancers that are complemented by ROR1-dependent, non-canonical Wnt5a signaling. Disclosures Kipps: Pharmacyclics Abbvie Celgene Genentech Astra Zeneca Gilead Sciences: Other: Advisor." @default.
• W2979836687 created "2019-10-18" @default.
• W2979836687 creator A5019344762 @default.
• W2979836687 creator A5031461345 @default.
• W2979836687 creator A5033222332 @default.
• W2979836687 creator A5036294739 @default.
• W2979836687 creator A5036828560 @default.
• W2979836687 creator A5060928962 @default.
• W2979836687 creator A5073680857 @default.
• W2979836687 creator A5087255205 @default.
• W2979836687 date "2015-12-03" @default.
• W2979836687 modified "2023-09-28" @default.
• W2979836687 title "Structural Features of ROR1 Required for Complexing with ROR2 and Enhancing Chemokine-Induced Migration and Leukemia-Cell Proliferation, Which Can be Blocked By the Anti-ROR1 Mab Cirmtuzumab (UC-961)" @default.
• W2979836687 doi "https://doi.org/10.1182/blood.v126.23.1741.1741" @default.
• W2979836687 hasPublicationYear "2015" @default.
• W2979836687 type Work @default.
• W2979836687 sameAs 2979836687 @default.
• W2979836687 citedByCount "0" @default.
• W2979836687 crossrefType "journal-article" @default.
• W2979836687 hasAuthorship W2979836687A5019344762 @default.
• W2979836687 hasAuthorship W2979836687A5031461345 @default.
• W2979836687 hasAuthorship W2979836687A5033222332 @default.
• W2979836687 hasAuthorship W2979836687A5036294739 @default.
• W2979836687 hasAuthorship W2979836687A5036828560 @default.
• W2979836687 hasAuthorship W2979836687A5060928962 @default.
• W2979836687 hasAuthorship W2979836687A5073680857 @default.
• W2979836687 hasAuthorship W2979836687A5087255205 @default.
• W2979836687 hasConcept C153911025 @default.
• W2979836687 hasConcept C170493617 @default.
• W2979836687 hasConcept C180361614 @default.
• W2979836687 hasConcept C185592680 @default.
• W2979836687 hasConcept C203014093 @default.
• W2979836687 hasConcept C23440912 @default.
• W2979836687 hasConcept C2775960820 @default.
• W2979836687 hasConcept C2777093181 @default.
• W2979836687 hasConcept C2778461978 @default.
• W2979836687 hasConcept C502942594 @default.
• W2979836687 hasConcept C54009773 @default.
• W2979836687 hasConcept C54355233 @default.
• W2979836687 hasConcept C55493867 @default.
• W2979836687 hasConcept C62478195 @default.
• W2979836687 hasConcept C81885089 @default.
• W2979836687 hasConcept C86803240 @default.
• W2979836687 hasConcept C95444343 @default.
• W2979836687 hasConceptScore W2979836687C153911025 @default.
• W2979836687 hasConceptScore W2979836687C170493617 @default.
• W2979836687 hasConceptScore W2979836687C180361614 @default.
• W2979836687 hasConceptScore W2979836687C185592680 @default.
• W2979836687 hasConceptScore W2979836687C203014093 @default.
• W2979836687 hasConceptScore W2979836687C23440912 @default.
• W2979836687 hasConceptScore W2979836687C2775960820 @default.
• W2979836687 hasConceptScore W2979836687C2777093181 @default.
• W2979836687 hasConceptScore W2979836687C2778461978 @default.
• W2979836687 hasConceptScore W2979836687C502942594 @default.
• W2979836687 hasConceptScore W2979836687C54009773 @default.
• W2979836687 hasConceptScore W2979836687C54355233 @default.
• W2979836687 hasConceptScore W2979836687C55493867 @default.
• W2979836687 hasConceptScore W2979836687C62478195 @default.
• W2979836687 hasConceptScore W2979836687C81885089 @default.
• W2979836687 hasConceptScore W2979836687C86803240 @default.
• W2979836687 hasConceptScore W2979836687C95444343 @default.
• W2979836687 hasLocation W29798366871 @default.
• W2979836687 hasOpenAccess W2979836687 @default.
• W2979836687 hasPrimaryLocation W29798366871 @default.
• W2979836687 hasRelatedWork W2040283204 @default.
• W2979836687 hasRelatedWork W2286862949 @default.
• W2979836687 hasRelatedWork W2467276934 @default.
• W2979836687 hasRelatedWork W2490060287 @default.
• W2979836687 hasRelatedWork W2530617547 @default.
• W2979836687 hasRelatedWork W2548434728 @default.
• W2979836687 hasRelatedWork W2567072251 @default.
• W2979836687 hasRelatedWork W2571522394 @default.
• W2979836687 hasRelatedWork W2575920423 @default.
• W2979836687 hasRelatedWork W2580077100 @default.
• W2979836687 hasRelatedWork W2583978870 @default.
• W2979836687 hasRelatedWork W2588938060 @default.
• W2979836687 hasRelatedWork W2594485645 @default.
• W2979836687 hasRelatedWork W2594884466 @default.
• W2979836687 hasRelatedWork W2886254130 @default.
• W2979836687 hasRelatedWork W2914777363 @default.
• W2979836687 hasRelatedWork W2917130052 @default.
• W2979836687 hasRelatedWork W2921567865 @default.
• W2979836687 hasRelatedWork W2981206373 @default.
• W2979836687 hasRelatedWork W3130898880 @default.
• W2979836687 isParatext "false" @default.
• W2979836687 isRetracted "false" @default.
• W2979836687 magId "2979836687" @default.
• W2979836687 workType "article" @default.